These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 192051)

  • 1. Changes of rat cerebellar guanosine 3',5'-cyclic phosphate by dopaminergic mechanisms in vivo.
    Burkard WP; Pieri L; Haefely W
    Adv Biochem Psychopharmacol; 1976; 15():315-24. PubMed ID: 192051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo changes of guanosine 3',5'-cyclic phosphate in rat cerebellum by dopaminergic mechanisms.
    Burkard WP; Pieri L; Haefely W
    J Neurochem; 1976 Jul; 27(1):297-8. PubMed ID: 182922
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacologically induced changes in the 3':5'-cyclic guanosine monophosphate content of rat cerebellar cortex: difference between apomorphine, haloperidol and harmaline.
    Biggio G; Costa E; Guidotti A
    J Pharmacol Exp Ther; 1977 Jan; 200(1):207-15. PubMed ID: 13199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different mechanisms mediating the decrease of cerebellar cGMP elicited by haloperidol and diazepam.
    Biggio G; Costa E; Guidotti A
    Adv Biochem Psychopharmacol; 1976; 15():325-35. PubMed ID: 192052
    [No Abstract]   [Full Text] [Related]  

  • 5. Scopolamine-induced hypermotility in rats is mediated via a dopaminergic system.
    Fink H; Morgenstern R
    Acta Biol Med Ger; 1980; 39(8-9):903-10. PubMed ID: 7282220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of dopaminergic agonists and antagonists on in vivo cyclic nucleotide content: relation of guanosine 3':5'- monophosphate (cGMP) changes in cerebellum to behavior.
    Breese GR; Mueller RA; Mailman RB
    J Pharmacol Exp Ther; 1979 May; 209(2):262-70. PubMed ID: 35602
    [No Abstract]   [Full Text] [Related]  

  • 7. Striato-cerebellar pathway controlling cyclic GMP content in the cerebellum: role of dopamine, GABA and enkephalins.
    Biggio G; Corda MG; Casu M; Gessa GL
    Adv Biochem Psychopharmacol; 1978; 18():227-44. PubMed ID: 206110
    [No Abstract]   [Full Text] [Related]  

  • 8. Change in brain guanosine 3',5'-monophosphate (cGMP) content by thyrotropin-releasing hormone.
    Mailman RB; Frye GD; Mueller RA; Breese GR
    J Pharmacol Exp Ther; 1979 Feb; 208(2):169-75. PubMed ID: 33261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclic AMP in retina and caudate nucleus: influence of dopamine and other agents.
    Makman MH; Brown JH; Mishra RK
    Adv Cyclic Nucleotide Res; 1975; 5():661-79. PubMed ID: 165691
    [No Abstract]   [Full Text] [Related]  

  • 10. Kainic acid-induced lesion of dopaminergic target cells in the striatum: consequences on the dynamics of cerebellar cGMP.
    Biggio G; Corda MG; Casu M; Gessa GL
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Aug; 304(1):5-7. PubMed ID: 211448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of chronic treatment with neuroleptics on the content of 3',5'-cyclic guanosine monophosphate in cerebellar cortex of rats.
    Biggio G; Corda MG; Casu M; Gessa GL
    Life Sci; 1978 Aug; 23(6):649-52. PubMed ID: 29201
    [No Abstract]   [Full Text] [Related]  

  • 12. CCK modulation of cerebellar afferents: dopaminergic involvement.
    Wood PL
    Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(3-4):513-8. PubMed ID: 2546180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of intrastriatal glutamic acid injection on rat cerebellar cyclic GMP levels.
    Lautié JP; Kouyoumdjian JC; Haidamous M; Lacombe C; Grignon L; Gonnard P
    J Neurochem; 1981 Sep; 37(3):801-3. PubMed ID: 6115892
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of general central nervous system depressants with and without calcium ionophore A23187 of rat cerebellar cyclic guanosine 3',5'-monophosphate.
    Dodson RA; Johnson WE
    Res Commun Chem Pathol Pharmacol; 1980 Aug; 29(2):265-80. PubMed ID: 6251522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Involvement of serotoninergic mechanisms in the circling behaviour induced by apomorphine and LSD 25 in rats (author's transl)].
    Jaton AL; Vigouret JM; Dravid A
    J Physiol (Paris); 1981; 77(2-3):405-11. PubMed ID: 7288655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of buspirone and diazepam on cGMP level in the rat cerebellum].
    Korneev AIa; Chan TB; Faktor MI
    Biull Eksp Biol Med; 1986 Sep; 102(9):292-4. PubMed ID: 3019447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effect of dopamine on acetylcholine release from caudate nucleus.
    Vizi SE; Rónai A; Hársing L; Knoll J
    Pol J Pharmacol Pharm; 1977; 29(3):201-11. PubMed ID: 887499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LY83583: an agent that lowers intracellular levels of cyclic guanosine 3',5'-monophosphate.
    Schmidt MJ; Sawyer BD; Truex LL; Marshall WS; Fleisch JH
    J Pharmacol Exp Ther; 1985 Mar; 232(3):764-9. PubMed ID: 2857787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the mechanism of the decrease in cerebellar cyclic GMP content elicited by opiate receptor agonists.
    Biggio G; Guidotti A; Costa E
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Jan; 296(2):117-21. PubMed ID: 189228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The haloperidol effect on the histofluorescence in the caudate nucleus of the rat brain treated with agonistic and antagonistic acetylcholine compounds.
    Wawrzyniak M; Cybulska R
    Folia Histochem Cytochem (Krakow); 1981; 19(3):143-8. PubMed ID: 7327444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.